drugset / Trial / NCT03972124
Cannabis for the Prophylactic Treatment of Migraine
RandomizedParallel-groupTriple-blindPrevention
Summary
This study will evaluate the efficacy and safety of cannabis for the treatment of chronic migraine headaches. Study subjects will be randomized to one of three groups: lower dose CBD, higher dose CBD or placebo.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CBD | Unknown | 100 mg | — |
| Comparator | CBD | Unknown | 200 mg | — |